1. Home
  2. BUR vs VCEL Comparison

BUR vs VCEL Comparison

Compare BUR & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Burford Capital Limited

BUR

Burford Capital Limited

HOLD

Current Price

$7.87

Market Cap

2.0B

Sector

Finance

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$32.57

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BUR
VCEL
Founded
2009
1989
Country
Guernsey
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.7B
IPO Year
2017
1996

Fundamental Metrics

Financial Performance
Metric
BUR
VCEL
Price
$7.87
$32.57
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$18.00
$58.50
AVG Volume (30 Days)
2.1M
527.5K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
1.62%
N/A
EPS Growth
N/A
60.00
EPS
0.28
0.32
Revenue
$413,360,000.00
$276,259,000.00
Revenue This Year
$73.95
$19.10
Revenue Next Year
$12.15
$17.95
P/E Ratio
$27.63
$98.34
Revenue Growth
N/A
16.45
52 Week Low
$7.61
$29.24
52 Week High
$14.61
$48.75

Technical Indicators

Market Signals
Indicator
BUR
VCEL
Relative Strength Index (RSI) 38.72 41.53
Support Level $7.61 $31.24
Resistance Level $9.73 $38.48
Average True Range (ATR) 0.32 1.34
MACD -0.01 -0.08
Stochastic Oscillator 25.13 36.04

Price Performance

Historical Comparison
BUR
VCEL

About BUR Burford Capital Limited

Burford Capital Ltd is a finance firm providing litigation finance, insurance, and risk transfer, law firm lending, corporate intelligence and judgment enforcement, and a wide range of investment activities. It operates in two segments: Principal Finance, which allocates capital to legal finance assets from its balance sheet, primarily as capital provision assets and in limited scope through interests in private funds managed by the company; Asset management and other services, which includes the provision of services to the legal industry, including litigation insurance; and other corporate. The geographical segments include the United States, United Kingdom, Singapore, Hong Kong, China, and, Australia.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: